Baylor Genetics to Provide PGx, Germline Genetic Testing to Veterans Affairs Department
Baylor Genetics to Provide PGx, Germline Genetic Testing to Veterans Affairs Department
Baylor Genetics’ multiyear national contract with the U.S. Department of Veterans Affairs will greatly expand veterans’ access to precision diagnostics—helping VA providers tailor medications, reduce adverse drug reactions, identify hereditary cancer risk, and ultimately support more timely, personalized care.
“Baylor Genetics is deeply honored to support the VA in expanding nationwide access to advanced precision diagnostics for veterans,” Kengo Takishima, Chairman and CEO of Baylor Genetics, said in a statement. “By providing high-quality genetic insights, we aim to empower VA providers with the tools they need to improve treatment outcomes and ensure that those who have served our country receive the best possible care.”